Effects of CoQ10 on Inflammatory Response in Cardiac Surgery
Status:
Not yet recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
Cardiovascular diseases are the leading causes of death and prescription drug use. Research
on certain dietary supplements looks promising as a way to help reduce risk factors. Previous
studies showed that CoQ10 levels were decreased in cardiovascular patients and worsening of
mitochondrial dysfunction was observed. The overall objective of this study is to determine
if supplementing with CoQ10 can reduce inflammatory risk factors in adults with cardiac
surgery, independent of other dietary or physical activity changes.